Archive for December 2011
Tax reforms help Aussie R&Ds; over the commercial line
After nearly a decade researching a skin cancer treatment for Australian biotech Peplin, which was acquired by Danish Leo Pharma, Dr Peter Welburn welcomes recent tax changes that would have been extremely beneficial when attempting to bring the product to market as a local company.
CFO Fast track
‘CFO moves at Telstra, ACP, Alumina, Gunns and Lend Lease.
Institutional therapy preferred for bond market
CFOs welcome government plans to make issuing retail bonds easier, but many would prefer to see incentives for institutional investors as well.
Checkmate in three moves, with or without caffeine
Success in business, like chess, is never achieved with one stunning move. But what about three moves?
Tough times for IPOs
The most recent Deloitte IPO survey shows the number of listings are up on last year but the value created is down.
New guidelines for underlying profit
A recent KPMG survey shows the use of underlying profit is increasing in importance as a communications tool so CFOs need to understand the guidance provided in the December release of the final ASIC ruling on its use.
Death by benchmarking
It has its place in highly competitive markets, but benchmarking won’t light the way to the untapped new markets
Archives
- December 2013 (6)
- November 2013 (14)
- October 2013 (16)
- September 2013 (18)
- August 2013 (12)
- July 2013 (25)
- June 2013 (20)
- May 2013 (22)
- April 2013 (33)
- March 2013 (62)
- February 2013 (45)
- January 2013 (36)
- December 2012 (40)
- November 2012 (38)
- October 2012 (49)
- September 2012 (30)
- August 2012 (26)
- July 2012 (27)
- June 2012 (54)
- May 2012 (67)
- April 2012 (52)
- March 2012 (53)
- February 2012 (64)
- January 2012 (7)
- December 2011 (7)
- November 2011 (2)
- October 2011 (4)